Medical News

RSS

Cardiac drug combats muscle cramps in ALS

A phase II study shows that the sodium channel blocker mexiletine has no specific safety concerns in patients with amyotrophic lateral sclerosis and, moreover, markedly reduces muscle cramps.

1 Mar 2016

CAMH, Impel NeuroPharma partner to advance novel treatment to alleviate depression

The Centre for Addiction and Mental Health and Impel NeuroPharma have signed a licensing agreement to advance a new neuropeptide-based therapeutic approach shown to be effective in treating depression.

1 Mar 2016

Promising therapeutic strategy for relieving neuropathic pain

A specific molecule involved in maintaining pain after a nerve injury has been identified and blocked in mice by Hiroshima University researchers. These results reveal a promising therapeutic strategy for treating neuropathic pain.

1 Mar 2016

Janssen ranked among 100 Best Companies to Work for in the UK

Janssen, a pharmaceutical company of Johnson & Johnson, is celebrating being ranked number 30 out of 100 Best Companies to Work for and being awarded the highest three star Best Companies Accreditation in research conducted by Best Companies in the UK and published by the Sunday Times.

1 Mar 2016

Advances in the field of MPI: an interview with Professor Kannan Krishnan

In around 2004, there was a Phillips paper that discussed a new imaging technique called MPI. At that time, I had an eager, promising graduate student named Matt Ferguson who wanted a project, so I asked him to take a look.

From Bruker BioSpin Division 1 Mar 2016

New international survey provides insights into emotional truths of living with IPF

An international survey of over 500 people living with idiopathic pulmonary fibrosis (IPF) in more than 20 countries worldwide reveals the real-life emotions faced by those with the devastating disease.

1 Mar 2016

Johns Hopkins Medicine expert offers tips to prevent Zika virus

People looking forward to a warm, sunny vacation may want to pack insect repellent for their trip.

1 Mar 2016

Rare Disease Day 2016: Boehringer Ingelheim launches new initiatives to raise awareness of IPF

Boehringer Ingelheim, working with pharmaphorum media, has brought together patients, patient groups and globally renowned clinicians to launch a report into IPF entitled Inspiration - a new initiative dedicated to raising awareness of IPF,1 a rare disease that is relatively unheard of, frequently misdiagnosed and little understood.

1 Mar 2016

Snoring and breathing problems can affect children's learning, concentration process

Children commonly snore from time to time and that is often harmless. But children with frequent snoring and breathing problems during sleep have an increased risk of having trouble concentrating and learning difficulties.

1 Mar 2016

Johns Hopkins researchers create new model to address patient safety, quality of care in outpatient centers

When implementing a unified, whole care delivery system, a strong organizational framework that includes the participation of all staff members — from the board room to the community practice — is critical, Johns Hopkins researchers report.

1 Mar 2016

NHS could continue to waste £10 million per year on treating preventable cold-related illness, NEA warns

Fuel poverty charity National Energy Action (NEA) is today [26 February] warning that the NHS could continue to waste well over a billion pounds a year on treating preventable cold-related illness.

1 Mar 2016

Young parents call for better advice to deal with fuel poverty

Young parents are calling for better advice to tackle fuel poverty as almost four million children in England live in families that are struggling to pay their energy bills, according to evidence gathered in a new report.

1 Mar 2016

Alpine HC introduces Reposa Synergy Hybrid Pressure Mattress

Introducing the Reposa Synergy by Alpine HC, an innovative hybrid mattress system that exemplifies synergy by combining exceptional comfort through specialist foams, with effective pressure distribution using integral air-foam cells. The end result? A superior pressure relieving experience for the user.

From Opera Care 1 Mar 2016

"Neoehrlichiosis" Internationally Diagnosed And Successfully Treated In Patients Without Immunodeficiency For The First Time

The intercellular bacteria "Candidatus Neoehrlichia", as e.g. Borrelia, can be transferred by ticks. Approx. 4.2 % of indigenous ticks are infected with this rarely explored bacterium which, until today, has been exclusively identified as pathogenic bacterium in patients with an impairment of the immune system, such as in case of leukaemia, rheumatism or after organ transplantation.

1 Mar 2016

New combination treatment shows promise for treating acute myeloid leukaemia

Walter and Eliza Hall Institute researchers have discovered that the treatment of the most deadly form of blood cancer may be improved by combining two recently developed drugs.

1 Mar 2016

Anti-bacterial fabrics show promise against superbugs

Antibiotics have proven to be a valuable weapon in the fight against infectious bacteria. However, due to the excess use of antibiotics in conventional treatments, overtime antibiotics have become less effective.

1 Mar 2016

Scientists start clinical trial to test new prostate cancer vaccine

Oxford University scientists have started a clinical trial to test a new vaccine against prostate cancer and are looking for volunteers to take part. The first four participants have already received this experimental vaccine at the Churchill Hospital in Oxford, and the second trial site has just been opened at the Royal Hallamshire Hospital in Sheffield.

1 Mar 2016

Preceyes, Nightstar partner to develop drug delivery technology for ocular surgery

Preceyes B.V. (NL) and Nightstar (UK) have entered into a collaboration for the development of a high-precision drug delivery technology in the eye. Nightstar will use the Preceyes robotic device to further refine the delivery of gene therapy to the subretinal space for a range of inherited retinal diseases.

1 Mar 2016

FDA announces availability of $2 million for rare disease research

The U.S. Food and Drug Administration today announced the availability of $2 million in research grants to fund natural history studies in rare diseases. The aim is to collect data on how specific rare diseases progress in individuals over time so that knowledge can inform and support product development and approval. This will be the first time the FDA will provide funding through its Orphan Products Grants to conduct these types of studies for rare diseases.

1 Mar 2016

Osteopathic manipulative treatment improves function in patients suffering from chronic low back pain

Studies published in the Journal of the American Osteopathic Association found that osteopathic manipulative treatment (OMT) reduced pain and improved function in patients suffering from chronic, nonspecific low back pain.

1 Mar 2016

Medical News

Cardiac drug combats muscle cramps in ALS

CAMH, Impel NeuroPharma partner to advance novel treatment to alleviate depression

Promising therapeutic strategy for relieving neuropathic pain

Janssen ranked among 100 Best Companies to Work for in the UK

Advances in the field of MPI: an interview with Professor Kannan Krishnan

New international survey provides insights into emotional truths of living with IPF

Johns Hopkins Medicine expert offers tips to prevent Zika virus

Rare Disease Day 2016: Boehringer Ingelheim launches new initiatives to raise awareness of IPF

Snoring and breathing problems can affect children's learning, concentration process

Johns Hopkins researchers create new model to address patient safety, quality of care in outpatient centers

NHS could continue to waste £10 million per year on treating preventable cold-related illness, NEA warns

Young parents call for better advice to deal with fuel poverty

Alpine HC introduces Reposa Synergy Hybrid Pressure Mattress

"Neoehrlichiosis" Internationally Diagnosed And Successfully Treated In Patients Without Immunodeficiency For The First Time

New combination treatment shows promise for treating acute myeloid leukaemia

Anti-bacterial fabrics show promise against superbugs

Scientists start clinical trial to test new prostate cancer vaccine

Preceyes, Nightstar partner to develop drug delivery technology for ocular surgery

FDA announces availability of $2 million for rare disease research

Osteopathic manipulative treatment improves function in patients suffering from chronic low back pain

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News